NYSE •
Healthcare •
Medical Instruments & Supplies •
Quote as of 05/15/2026
Company Profile
IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNYSE
Market Capitalization11.13 mln
Float2.70 mln
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
4
/ 100
Severely lagging
Debt / Equity
0.25
Very low leverage
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Regentis Biomaterials is an Israeli medical company, founded in 2004 and headquartered in Herzliya, that focuses on healing damaged tissue in the human body. Its main product line centers on a gel-based material designed to repair cartilage and other injured tissues, with one treatment specifically targeting knee cartilage damage currently being evaluated in a Phase II clinical trial. The company sells its products primarily in the United States.
